Clinical Trial Update: The Study of CYP2C19 Genotype-Guided Clopidogrel Treatment Models [NA]

View source ↗

Summary

Completed clinical trial evaluating CYP2C19 genotype-guided clopidogrel treatment models with results posted in 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Thrombosis

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Vistamedi Ltd. | Conditions: Coronary Artery Disease, Clopidogrel Resistance | NA | Status: COMPLETED | Results posted: 2025-09-26